LEICESTERSHIRE PARTNERSHIP 2021

 

A university teaching and research-active Trust

Bridge Park Plaza

Bridge Park Road

Thurmaston

Leicester

LE4 8PQ

Direct dial: (0116) 295 5296 Email: lpt.foi@nhs.net  

Tel: 0116 295 1350

www.leicspart.nhs.uk Our ref: FOI/2223/SG11832

 

31 May 2022

 

wmicklewright@yahoo.co.uk

 

Dear Wendy Micklewright,

Request under Freedom of Information Act 2000 – Ref: FOI/2223/SG11832

Thank you for your request for information under the Freedom of Information Act 2000, received on 5 May 2022 regarding ECT, Serious Incidents, medication errors and the use of restraint and seclusion. Please find below our response to your request:

REQUEST:

Please provide ECT information under the FOI act to the following questions:

1.Please supply patient’s information ECT leaflet.

2.Please supply patient ECT consent form

3.Please supply any ECT reports/investigations

4.How many ECT in 2021?

5.What proportion of patients were men/women?

6.How old were they?

7.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

8.How many were receiving ECT for the first time?

9.How many patients consented to ECT?

10.How many ECT complaints were investigated outside the NHS and CCG?

11.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?

12.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)?

13.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?

14.How many patients have suffered complications during and after ECT and what were those complications?

15.Have there been any formal complaints from patients/relatives about ECT?

16.If so, what was their concerns?

17.How many patients report memory loss/loss of cognitive function?

18.What tests are used to assess memory loss/loss of cognitive function?

19.Have MRI or CT scans been used before and after ECT?

20.If so, what was the conclusion?

21.How does the Trust plan to prevent ECT in the future?

Please provide SERIOUS INCIDENT information under the FOI act to the following questions:

1.Please supply any serious incident reports/investigations?

2.How many SERIOUS INCIDENT REPORTS in 2021?

3.What proportion of patients were men/women?

4.How old were they?

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

6.How many SERIOUS INCIDENT REPORTS were investigated outside the NHS and CCG?

7.How many patients died during or 1 month after SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?

8.How many patients died within 6 months after SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?

9.How many patients died by suicide within 6 months of receiving SERIOUS INCIDENT REPORTS (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?

10.How many patients have suffered complications during and after SERIOUS INCIDENT REPORTS and what were those complications?

11.Have there been any formal complaints from patients/relatives about SERIOUS INCIDENT REPORTS?

12.If so, what was their concerns?

13.How does the Trust plan to prevent SERIOUS INCIDENTS in the future?

Please provide restraints information under the FOI act to the following questions:

1.Please supply any Restraints/investigations?

2.How many RESTRAINTS in 2021?

3.What proportion of patients were men/women?

4.How old were they?

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

6.How many RESTRAINTS were investigated outside the NHS and CCG?

7.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?

8.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?

9.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?

10.How many patients have suffered complications during and after RESTRAINTS and what were those complications?

11.Have there been any formal complaints from patients/relatives about RESTRAINTS?

12.If so, what was their concerns?

13.Are counts of forced injections available?

14.How does the Trust plan to reduce restraints in the future?

Please provide SECLUSION information under the FOI act to the following questions:

1.Please supply any SECLUSION reports/investigations

2.How many SECLUSIONS in 2021?

3.What proportion of patients were men/women?

4.How old were they?

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

6.How many SECLUSIONS were investigated outside the NHS and CCG?

7.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?

8.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?

9.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?

10.How many patients have suffered complications during and after SECLUSION and what were those complications?

11.Have there been any formal complaints from patients/relatives about SECLUSION?

12.If so, what was their concerns?

13.How does the Trust plan to reduce SECLUSIONS in the future?

Please provide MEDICATION ERRORS information under the FOI act to the following questions:

1.Please supply any MEDICATION ERRORS reports/investigations

2.How many MEDICATION ERRORS in 2021?

3.What proportion of patients were men/women?

4.How old were they?

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

6.How many MEDICATION ERRORS were investigated outside the NHS and CCG?

7.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?

8.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?

9.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?

10.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?

11.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?

12.If so, what was their concerns?

13.How does the Trust plan to prevent MEDICATION ERRORS in the future?

OUR RESPONSE: In terms of any reports or investigations held, we are withholding this information since we consider the exemption under Section 40(2) of the Freedom of Information Act 2000 applies to it, as it constitutes the personal data of the individuals concerned.  

In addition, from our preliminary assessment, we estimate that compliance with your request would exceed the appropriate costs limit under section 12 of the Freedom of information Act 2000, currently £450, as much of the information is not centrally recorded and we would need to check multiple sets of records. However, in an attempt to be helpful, we are able to provide the following information:

ECT Information:  

1.  Please see attached leaflets.
2.  Please see attached ECT consent form.  
4.  57.
5.  37 Women and 20 Men.
6.  2 patients under the age of 40, 17 between the ages of 40-60 and 38 over the age of 60 years.
9.  33.
10. 0.
11. 2 patients have died from an unknown cause, outcome to be determined.
13. 1 known suicide, unknown if ECT was a cause.
14. One patient experience a prolonged seizure and one desaturation; both were attended to via Accident and Emergency.  
15. No formal complaints received there was one informal concern received.  
16. The concern was regarding the communication between the service and the patient.  
17. 1 reported. Treatment changed to Unilateral.
18. Montreal Cognitive Assessment Tool (MOCA), orientation questions pre- treatment and post treatment and ongoing prescription memory assessment.
19. No.
20. N/A.
21. There are none currently.

Serious Incidents: Please find attached the Trust’s Incident Reporting and Management Policy.  

2.  148.

Restraints:

2.  2585.

3.  1670 Female, 795 Male, 120 gender not known.

5.   1143. Please note, 162 patient ethnicity group not known.

14. The Trust has a plan in accordance with the Department of Health ‘Positive and Proactive Care: reducing the need for restrictive interventions’.

Seclusion: Please find attached the Trust’s Seclusion and Long Term Segregation Policy. 

2.  380.

3.  122 Female, 257 Male, 1 gender not known.

5.   239. Please note, 9 patient ethnicity group not known.

13. The Trust has a plan in accordance with the Department of Health guidance ‘Positive and Proactive Care: reducing the need for restrictive interventions’.

Medication Errors: Please find attached the Trust’s Medication Error Policy.  

2.         OUR RESPONSE: 796.

I trust this response is helpful to you. However, if you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Requests for an internal review should be submitted within two months of the date of receipt of the response to your original request and should be addressed to: Hannah Plowright, Deputy Data Protection Officer, Unit 2, Bridge Park Plaza, Thurmaston, Leicester LE4 8BL

If you remain dissatisfied with the handling of your request, you have a right of appeal to the Information Commissioner at: The Information Commissioner's Office, Wycliffe House, Water Lane, Wilmslow, Cheshire SK9 5AF. Phone: 0303 123 1113. Website: www.ico.gov.uk  . There is no charge for making an appeal.

If you require any further assistance, please do not hesitate to contact me. Please remember to quote the reference number above in any communications.

Yours sincerely,

 

 

Data Privacy Team